Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

6.210 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	6.210
Bid (Size)	6.210 (400)
Ask (Size)	6.240 (600)
Prev. Close	6.210
Today's Range	6.210 - 6.210
52wk Range	2.120 - 7.550
Shares Outstanding	38,886,465
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles

January 08, 2026

In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index (RUT) surged to a new record high on January 8, 2026, signaling a definitive breakout for small-cap stocks. As...

Via MarketMinute

Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears

January 07, 2026

The Russell 2000 index, the primary benchmark for American small-cap stocks, suffered a significant sell-off on Wednesday, January 7, 2026, as a batch of conflicting economic data sparked fears that...

Via MarketMinute

Performance

YTD	-3.7%	-3.7%
1 Month	+1.8%	+1.8%
3 Month	-7.2%	-7.2%
6 Month	+54.1%	+54.1%
1 Year	+98.4%	+98.4%

More News

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate ↗

September 26, 2025

Via Stocktwits

FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film ↗

September 04, 2025

Via Stocktwits

Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 24, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Jim Cramer: Joby Is 'Losing Too Much Money' ↗

November 12, 2025

Via Benzinga

Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 05, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

November 04, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

November 03, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting

October 30, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

October 27, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™

October 08, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Friday's session: gap up and gap down stocks ↗

September 26, 2025

Via Chartmill

Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday ↗

September 26, 2025

Via Benzinga

ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment ↗

September 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 19, 2025

Via Benzinga

CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday ↗

September 19, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

September 19, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 04, 2025

Via Benzinga

Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday ↗

September 04, 2025

Via Benzinga

FDA Confirms Direct Review Path For Aquestive's Allergy Treatment ↗

September 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 04, 2025

Via Benzinga

Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™

September 04, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

August 26, 2025

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Aquestive Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aquestive Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aquestive Therapeutics, Inc. - Common Stock trade on?

Aquestive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aquestive Therapeutics, Inc. - Common Stock?

The ticker symbol for Aquestive Therapeutics, Inc. - Common Stock is AQST on the Nasdaq Stock Market

What is the current price of Aquestive Therapeutics, Inc. - Common Stock?

The current price of Aquestive Therapeutics, Inc. - Common Stock is 6.210

When was Aquestive Therapeutics, Inc. - Common Stock last traded?

The last trade of Aquestive Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET

What is the market capitalization of Aquestive Therapeutics, Inc. - Common Stock?

The market capitalization of Aquestive Therapeutics, Inc. - Common Stock is 241.48M

How many shares of Aquestive Therapeutics, Inc. - Common Stock are outstanding?

Aquestive Therapeutics, Inc. - Common Stock has 241M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.